As a consequence, the positive association observed specifically in EAT between L-Gal 9 and CD206 expression in CHD patients might confirm our hypothesis of a L-Gal 9 signaling toward an anti-inflammatory M2 profile in CHD patients, to compensate a local cardiac AT low-grade inflammation (36) (Graphical abstract, point b). Here, MRC1 is linked to coronary artery disorder.